Qual é o preço para Ainos, Inc. (AIMD)

O preço para Ainos, Inc. (AIMD) é $1.49

Qual é a capitalização de mercado para Ainos, Inc. (AIMD)

A capitalização de mercado para Ainos, Inc. (AIMD) é $10.94M

Histórico de Preços de Ainos, Inc. (AIMD)

Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.

Ano	Desempenho
2026 (TTM)	6.80%
2025	-6.53%
2024	-82.92%
2023	-21.75%
2022	-92.69%
2021	0.00%

Ano

Desempenho

2026 (TTM)

6.80%

2025

-6.53%

2024

-82.92%

2023

-21.75%

2022

-92.69%

2021

0.00%

Empresa	Preço da ação	Variação 1a%	País
Vertex Pharmaceuticals Incorporated VRTX.US	$515.58	32.24%	US
Argenx SE ARGX.US	$992.01	50.00%	NL
CSL Limited CSL.AX	$112.11	-36.37%	AU
Lonza Group AG LONN.SW	$736.64	6.99%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.06K	-6.98%	KR

Empresa

Preço da ação

Variação 1a%

País